| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 02/08/1995 | EP0637299A1 20-methyl-substituted vitamin d derivates. |
| 02/08/1995 | EP0637239A1 Method of promoting nitrogen retention in humans |
| 02/08/1995 | EP0637237A1 Calcium receptor-active molecules |
| 02/08/1995 | EP0637203A1 Regulation of the immune system |
| 02/08/1995 | CN1098411A Oxazolidinedione derivatives, their production and use |
| 02/08/1995 | CN1098406A New benzamide derivatives, processes for the preparation thereof and pharmaceutical composition comprising the same |
| 02/07/1995 | US5387615 L-deprenyl for treating immune system dysfunction and compositions for same |
| 02/07/1995 | US5387582 Vitamin D analogues |
| 02/02/1995 | WO1995003405A2 Enzymatic method for modification of recombinant polypeptides |
| 02/02/1995 | WO1995003313A1 Novel silylated benzylamine derivatives, salts thereof, methods of manufacture and pharmaceutical compositions containing them |
| 02/02/1995 | WO1995003305A1 Fused benzazepine derivative and pharmaceutical composition containing the same |
| 02/02/1995 | WO1995003304A1 Novel 9-n-bicyclic nucleoside agents useful as selective inhibitors of proinflammatory cytokines |
| 02/02/1995 | WO1995003290A1 Benzo-fused lactams promote release of growth hormone |
| 02/02/1995 | WO1995003271A1 2-amino-4-phenyl-4-oxo-butyric acid derivatives with kynureninase and/or kynurenine-3-hydroxylase inhibiting activity |
| 02/02/1995 | WO1995003266A1 10-substituted 1,8-dihydroxy-9(10h) anthracenone pharmaceuticals |
| 02/02/1995 | CA2167821A1 New silylated benzylamine derivatives and their salts; process for producing the same and pharmaceutical compositions containing them |
| 02/02/1995 | CA2167507A1 Benzo-fused lactams promote release of growth hormone |
| 02/02/1995 | CA2166870A1 Enzymatic method for modification of recombinant polypeptides |
| 02/02/1995 | CA2145067A1 10-substituted 1,8-dihydroxy-9(10h) anthracenone pharmaceuticals |
| 02/02/1995 | CA2144521A1 2-amino-4-phenyl-4-oxo-butyric acid derivatives with kynureninase and/or kynurenine-3-hydroxylase inhibiting activity |
| 02/01/1995 | EP0636632A2 Non-reducing oligosaccharides and their production and use |
| 02/01/1995 | EP0636369A1 Pyrimidones and imidazolinones for treatment of shock |
| 02/01/1995 | EP0636367A1 Use of phenylalkylamines for producing cholesterol lowering agents |
| 02/01/1995 | EP0636124A1 3,4-dihydro-2h-1,2,4-benzothiadiazine-1,1-dioxide-3-carboxylic acid derivatives, preparation thereof and drugs containing same |
| 02/01/1995 | EP0636117A1 Use of pyruvamide and selected pyruvyl-amino acids |
| 02/01/1995 | EP0636027A1 Angiotensin ii antagonists against disorders associated with impaired neuronal conduction velocity, especially diabetic neuropathy |
| 02/01/1995 | EP0636023A1 Aminoguanidine spray drying process |
| 02/01/1995 | EP0599987A4 Method for lowering blood lipid levels. |
| 02/01/1995 | EP0556308B1 Oxysulfonyl urea acat inhibitors |
| 02/01/1995 | EP0469125B1 Substituted 1-(alkoxy-iminoalkyl)imidazole derivatives |
| 02/01/1995 | CN1098099A Hexahydronaphthalene ester derivatives, their preparation and their therapeutic uses |
| 01/31/1995 | US5385932 Anticholesterol, antilipemic agents |
| 01/31/1995 | US5385930 Treating central nervous system disorders like anxiety and depression |
| 01/31/1995 | US5385929 [(Hydroxyphenylamino) carbonyl] pyrroles |
| 01/31/1995 | US5385919 Antidiabetic agents |
| 01/31/1995 | US5385912 Multicyclic tertiary amine polyaromatic squalene synthase inhibitors |
| 01/31/1995 | US5385740 Biologically active material characterized by catabolic activity generally associated with cachexia-inducing tumors, preparations, production and uses thereof |
| 01/31/1995 | CA1334197C Hetera-aliphatic carboxamides |
| 01/26/1995 | WO1995002692A1 Modified alpha-lactalbumin |
| 01/26/1995 | WO1995002602A1 Imidazo(1,2-a)pyrazin-4-one derivatives for use as ampa and nmda receptor antagonists |
| 01/26/1995 | WO1995002601A1 IMIDAZO[1,2-a]PYRAZINE-4-ONE, PREPARATION THEREOF AND DRUGS CONTAINING SAME |
| 01/26/1995 | WO1995002593A1 Piperazine derivatives and salts thereof |
| 01/26/1995 | WO1995002591A1 Tri-substituted imidazoles having multiple therapeutic properties |
| 01/26/1995 | WO1995002588A1 Use of coumarins and carbostyrils as pla2-inhibitors, new coumarins and carbostyrils, process for preparing the same and medicaments |
| 01/26/1995 | WO1995002585A1 Enanthioselective preparation of thiazole derivatives |
| 01/26/1995 | WO1995002577A1 Novel vitamin d analogues |
| 01/26/1995 | WO1994028014A3 Peptide inhibitors of urokinase receptor activity |
| 01/26/1995 | CA2167311A1 Tri-substituted imidazoles having multiple therapeutic properties |
| 01/26/1995 | CA2167287A1 Enantioselective process for thiazole intermediates |
| 01/26/1995 | CA2167169A1 Imidazo[1,2-a]pyrazin-4-one, preparation thereof and drugs containing same |
| 01/26/1995 | CA2167155A1 Modified alpha-lactalbumin |
| 01/26/1995 | CA2167071A1 Use of coumarins and carbostyrils as pla2 inhibitors, new coumarins and carbostyrils, processes for the production thereof and pharmaceutical agents |
| 01/26/1995 | CA2162040A1 Novel vitamin d analogues |
| 01/26/1995 | CA2143203A1 Piperazine derivatives and salts thereof |
| 01/25/1995 | EP0635573A2 Process for the preparation of native human glicentin |
| 01/25/1995 | EP0635501A1 Tris carbamic acid esters: inhibitors of cholesterol absorption; inhibitors of ACAT and CEH |
| 01/25/1995 | EP0635270A1 Parathyroid hormone and raloxifene for increasing bone mass |
| 01/25/1995 | EP0635264A2 Antiestrogens as hypoglycemic agents |
| 01/25/1995 | EP0635263A2 Angiotensin (AII) antagonists as inhibitors of the growth of adipose tissue |
| 01/25/1995 | EP0635017A1 Indole derivatives as 5-ht1 agonists |
| 01/25/1995 | EP0635007A1 Heterocyclic compounds and their use in the treatment of type ii-diabetes |
| 01/25/1995 | EP0634934A1 Method of treatment of hiv-seropositive individuals with dietary whey proteins |
| 01/25/1995 | EP0634931A1 The use of quinoline-3-carboxamide compounds for treatment of diabetes |
| 01/25/1995 | EP0600875A4 Purification of recombinant apolipoprotein e from bacteria. |
| 01/25/1995 | CN1097758A Pyrrolopyrimidines |
| 01/25/1995 | CN1027503C Crystalline salt of 4-(di-n-propyl) amino-6-aminocarbonyl-1,3,4,5-tetrahydrohbonz|cd¨indole |
| 01/24/1995 | US5384319 Aminoalkylphenyl compounds |
| 01/24/1995 | US5384314 Acne; gland and skin disorders |
| 01/24/1995 | US5384144 Suitable for patients suffering from hypercholesterolemia |
| 01/24/1995 | US5384136 Gluten in dough |
| 01/24/1995 | US5383324 Method for manufacturing and storing stable bicarbonate solutions |
| 01/24/1995 | CA2128560A1 Substituted piperazines, their preparation process and pharmaceutical compositions containing them |
| 01/24/1995 | CA2038409C Use of tenidap to inhibit activation of collagenase and to inhibit the activity of myeloperoxidase |
| 01/24/1995 | CA1334100C Benzocycloheptene compositions, process for their preparation thereof and pharmaceutical compositions holding same |
| 01/23/1995 | CA2128464A1 Bicyclic heterocyclic compounds, pharmaceutical preparations containing these compounds and processes for their preparation |
| 01/23/1995 | CA2128376A1 Parathyroid hormone and raloxifene for increasing bone mass |
| 01/22/1995 | CA2128116A1 Tris carbamic acid esters: inhibitors of cholesterol absorption |
| 01/19/1995 | WO1995001789A1 Arsenic medicaments for the treatment of chronic fatigue syndrome |
| 01/18/1995 | EP0634173A1 24-epi-1-alpha-hydroxyvitamin D2 for treating osteoporosis |
| 01/18/1995 | EP0633779A1 USE OF $g(b)-CARBOLINES |
| 01/18/1995 | EP0563112B1 Enhanced bioavailability pharmaceutical composition containing probucol |
| 01/18/1995 | EP0466768B1 Short-chain triglycerides |
| 01/18/1995 | CN1097420A Sulfonate and carbamate derivatives of 3-aroylbenzo|B¨thiophenes |
| 01/17/1995 | US5382593 Antioxidants or anticoagulants |
| 01/17/1995 | US5382574 Diabetes |
| 01/17/1995 | US5382569 Hexapeptides for cardiovascular disorders |
| 01/17/1995 | US5382443 Ready-to-eat cereals containing extruded pre-wetted psyllium |
| 01/17/1995 | CA2128160A1 Cation-complexed polysaccharides |
| 01/17/1995 | CA1334004C Essential fatty acid compositions |
| 01/17/1995 | CA1334003C Skin improving composition containing gla or dgla |
| 01/17/1995 | CA1333997C Cholesterol-lowering combination compositions of guar gum and niacin |
| 01/14/1995 | CA2127735A1 Pyrimidones and imidazolinones for treatment of shock |
| 01/12/1995 | WO1995001326A1 Anti-atherosclerotic diaryl compounds |
| 01/12/1995 | CA2166413A1 Anti-atherosclerotic diaryl compounds |
| 01/11/1995 | EP0633261A1 Quinoline-3-acetic acid derivative, process for producing the same, and use thereof |
| 01/11/1995 | EP0632829A1 Thrombin receptor antagonists |
| 01/11/1995 | EP0632726A1 A method for treating kaposi's sarcoma and blocking or inhibiting vascular permeability |
| 01/11/1995 | EP0544696B1 Hypoglycemic hydroxyurea derivatives |
| 01/10/1995 | US5380742 4H-thieno[3,4-c]pyrrole derivatives |
| 01/10/1995 | US5380726 Interleukin inhibitors |